A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

Takeo Fujii, Hiroko Masuda, Yee Chung Cheng, Fei Yang, Aysegul A. Sahin, Yasuto Naoi, Yuki Matsunaga, Akshara Raghavendra, Arup Kumar Sinha, Jose Rodrigo Espinosa Fernandez, Anjali James, Keisuke Yamagishi, Tomoko Matsushima, Robert Schuetz, Debu Tripathy, Sachiyo Tada, Rubie S. Jackson, Shinzaburo Noguchi, Seigo Nakamura, Jared D. AcobaNaoto T. Ueno

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores'. Together they form a unique fingerprint.

Medicine & Life Sciences